This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Insilico Medicine IP Limited. Active years: 2025.
Company Filing History:
Years Active: 2025
Title: Anton S Vantskul: Innovator in Pharmaceutical Science
Introduction
Anton S Vantskul is a prominent inventor based in Moscow, Russia. He has made significant contributions to the field of pharmaceutical science, particularly in the development of innovative compounds for treating various medical conditions. His work focuses on advancing therapeutic options for immune disorders, inflammatory disorders, and cancer.
Latest Patents
Anton S Vantskul holds a patent for "Bycyclic JAK inhibitors and uses thereof." This patent includes compounds of Formulas (I), (II), (III), and (IV), along with their subformulas. The patent outlines pharmaceutical compositions that incorporate these compounds and describes methods for their use in treating a range of health issues.
Career Highlights
Vantskul is associated with Insilico Medicine IP Limited, a company known for its cutting-edge research in artificial intelligence and drug discovery. His role at the company has allowed him to contribute to the development of novel therapeutic agents that have the potential to transform patient care.
Collaborations
Anton S Vantskul collaborates with Aleksandrs Zavoronkovs, a fellow innovator in the field. Their partnership exemplifies the collaborative spirit that drives advancements in pharmaceutical research.
Conclusion
Anton S Vantskul's work in developing JAK inhibitors represents a significant step forward in the treatment of complex medical conditions. His contributions continue to influence the pharmaceutical landscape, paving the way for future innovations.